top of page
Home
All News
Members
More
Use tab to navigate through the menu items.
Search
Rx News
News
Trials
Cases
Log In
All Posts
Guidelines
Clinical Trials
Patient Stories & PEL
Case Reports
New Approvals
Spotlight
Sacubitril/Valsartan showed a greater reduction of NT-proBNP in HFpEF patients: PARAMOUNT Study
Patients with documented left ventricular ejection fraction (LVEF) ≥ 50% are considered to have heart failure (HF) with preserved...
Dr. Anuradha Mallya
Sep 9, 2025
3 min read
Back to Top
bottom of page
